Azafaros: Azafaros to Present at J.P. Morgan's 43rd Annual Healthcare Conference

Azafaros, a company focused on developing treatments for the unmet needs of patients with rare lysosomal storage disorders, today announced that it will present at J.P. Morgan's 43rd Annual Health...